118 related articles for article (PubMed ID: 15708846)
1. LGR8 signal activation by the relaxin-like factor.
Büllesbach EE; Schwabe C
J Biol Chem; 2005 Apr; 280(15):14586-90. PubMed ID: 15708846
[TBL] [Abstract][Full Text] [Related]
2. The mode of interaction of the relaxin-like factor (RLF) with the leucine-rich repeat G protein-activated receptor 8.
Büllesbach EE; Schwabe C
J Biol Chem; 2006 Sep; 281(36):26136-43. PubMed ID: 16844694
[TBL] [Abstract][Full Text] [Related]
3. The "hot wires" of the relaxin-like factor (Insl3).
Schwabe C; Büllesbach EE
Ann N Y Acad Sci; 2009 Apr; 1160():93-8. PubMed ID: 19416166
[TBL] [Abstract][Full Text] [Related]
4. Chemical synthesis and biological activity of rat INSL3.
Smith KJ; Wade JD; Claasz AA; Otvos L; Temelcos C; Kubota Y; Hutson JM; Tregear GW; Bathgate RA
J Pept Sci; 2001 Sep; 7(9):495-501. PubMed ID: 11587188
[TBL] [Abstract][Full Text] [Related]
5. Partial cDNA sequence of a relaxin-like factor (RLF) receptor, LGR8 and possible existence of the RLF ligand-receptor system in goat testes.
Siqin ; Nakai M; Hagi T; Kato S; Pitia AM; Kotani M; Odanaka Y; Sugawara Y; Hamano K; Yogo K; Nagura Y; Fujita M; Sasada H; Sato E; Kohsaka T
Anim Sci J; 2010 Dec; 81(6):681-6. PubMed ID: 21108688
[TBL] [Abstract][Full Text] [Related]
6. Defining the LGR8 residues involved in binding insulin-like peptide 3.
Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA
Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281
[TBL] [Abstract][Full Text] [Related]
7. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135.
Liu C; Eriste E; Sutton S; Chen J; Roland B; Kuei C; Farmer N; Jörnvall H; Sillard R; Lovenberg TW
J Biol Chem; 2003 Dec; 278(50):50754-64. PubMed ID: 14522968
[TBL] [Abstract][Full Text] [Related]
8. Structure of the transmembrane signal initiation site of the relaxin-like factor (RLF/INSL3).
Büllesbach EE; Schwabe C
Biochemistry; 2007 Aug; 46(34):9722-7. PubMed ID: 17676766
[TBL] [Abstract][Full Text] [Related]
9. Relaxin-like bioactivity of ovine Insulin 3 (INSL3) analogues.
Claasz AA; Bond CP; Bathgate RA; Otvos L; Dawson NF; Summers RJ; Tregear GW; Wade JD
Eur J Biochem; 2002 Dec; 269(24):6287-93. PubMed ID: 12473125
[TBL] [Abstract][Full Text] [Related]
10. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2.
Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD
Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan B27 in the relaxin-like factor (RLF) is crucial for RLF receptor-binding.
Büllesbach EE; Schwabe C
Biochemistry; 1999 Mar; 38(10):3073-8. PubMed ID: 10074360
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cross-links arrest the C-terminal region of the relaxin-like factor in an active conformation.
Büllesbach EE; Schwabe C
Biochemistry; 2004 Jun; 43(25):8021-8. PubMed ID: 15209497
[TBL] [Abstract][Full Text] [Related]
13. Identification of relaxin-3/INSL7 as a ligand for GPCR142.
Liu C; Chen J; Sutton S; Roland B; Kuei C; Farmer N; Sillard R; Lovenberg TW
J Biol Chem; 2003 Dec; 278(50):50765-70. PubMed ID: 14522967
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
15. Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.
Yan Y; Cai J; Fu P; Layfield S; Ferraro T; Kumagai J; Sudo S; Tang JG; Giannakis E; Tregear GW; Wade JD; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():35-9. PubMed ID: 15956685
[TBL] [Abstract][Full Text] [Related]
16. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, conformation, receptor binding and biological activities of monobiotinylated human insulin-like peptide 3.
Fu P; Layfield S; Ferraro T; Tomiyama H; Hutson J; Otvos L; Tregear GW; Bathgate RA; Wade JD
J Pept Res; 2004 Feb; 63(2):91-8. PubMed ID: 15009530
[TBL] [Abstract][Full Text] [Related]
18. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
19. Relaxin, the relaxin-like factor and their receptors.
Schwabe C; Büllesbach EE
Adv Exp Med Biol; 2007; 612():14-25. PubMed ID: 18161478
[TBL] [Abstract][Full Text] [Related]
20. Expression and localization of RLF/ INSL3 receptor RXFP2 in boar testes.
Kohsaka T; Sagata D; Minagawa I; Kohriki H; Pitia AM; Sugii Y; Morimoto M; Uera N; Shibata M; Sasada H; Hasegawa Y
Ital J Anat Embryol; 2013; 118(1 Suppl):23-5. PubMed ID: 24640564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
